Baricitinib, Methotrexate, or Combination in Patients with Rheumatoid Arthritis and no or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Arthritis Rheumatol 2016. DOI 10.1002/art.39953. Accepted article
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Rheumatol 2016. DOI 10.1002/art.39953. Accepted article
Arthritis Res Ther 2016; 18:211. DOI 10.1186/s13075-016-1108-9
Arthritis Res Ther 2016; 18:198. DOI.10.1186/s13075-016-9
Arthritis Care Res 2016; Accepted article. DOI 10.1002/acr.23004
Arthritis Care Res 2016; Accepted article. DOI 10.1002/acr.23008.
Rheumatology (Oxford) 2016; DOI 10.1093/rheumatology/kew325
Arthritis Rheumatol 2016; Accepted article DOI 10.1002/art-39808 [Epub 2016]
Drug Saf. 2016 June 9; 39:755–762; DOI 10.1007/s40264-016-0431-z [Epub ahead of print]
Arthritis Research & Therapy. 2016. DOI 10.1186/s13075-016-1049-3 [Epub ahead of print]
Ann Rheum Dis. 2016 Jun;75:1057-64. doi: 10.1136/annrheumdis-2015-208279. Epub 2015 Dec 15